G. Tosi et al., HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines, EUR J IMMUN, 30(1), 2000, pp. 19-28
Human macrophage and T cell lines were stably transfected with HIV-1 wild-t
ype Tat or Tat mutants in the cysteine-rich region displaying trans-dominan
t negative effects on HIV-1 life cycle. The expression of HLA class I and c
lass II molecules was not affected by wild-type Tat. Tat mutants, instead,
profoundly down-regulated in a dose-dependent fashion the expression of cla
ss II, but not of class I, in both cell types by acting at the transcriptio
nal level. Down-regulation was manifested on constitutive and IFN-gamma-ind
uced class II gene expression and did not correlate with reduced transcript
ion of the AlR-1 gene product CIITA, the major transcriptional activator of
class II genes, indicating that Tat mutants did not act by inhibiting AlR-
1 gene expression. Class II down-modulation had important functional implic
ations in macrophages, as both antigen processing and presenting capacity w
ere inhibited. These results represent the first evidence that a modified H
IV-1 Tat product can act as a potent immunosuppressor by inhibiting the HLA
class II expression necessary for triggering both cellular and humoral res
ponses against pathogens. The use of these HIV-1 Tat mutants also discloses
new opportunities to investigate the molecular mechanisms underlying the c
oordinate HLA class II gene transcription.